Physician profile
Shipra Kaicker
NPI 1194710574
$13,718.49
in general payments reported to CMS, 2019-2025
10 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2021: $119 · 2022: $4,609 · 2023: $498 · 2024: $7,800 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Travel and Lodging: $1,429 · Food and Beverage: $1,236 · Education: $33.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Travel and Lodging | $1,429.31 |
| Food and Beverage | $1,236.28 |
| Education | $33.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $7,767.27 | 2024 | |
| Global Blood Therapeutics, INC. | $4,602.73 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $435.26 | 2023-2025 | Pyrukynd |
| Novartis Pharmaceuticals Corporation | $409.57 | 2019-2023 | Promacta |
| Sobi, INC | $124.97 | 2022 | |
| Novo Nordisk INC | $121.58 | 2025 | |
| Rigel Pharmaceuticals, INC. | $113.61 | 2019 | |
| Fennec Pharmaceuticals, INC. | $82.89 | 2023 | Pedmark |
| Bio Products Laboratory USA, INC. | $60.61 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shipra Kaicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.